Cargando…
Abnormal expression of CXCL13, MIF and IL-35 in patients with primary Sjögren’s syndrome and its relationship with disease severity
INTRODUCTION: The aim of the study was to detect the saliva chemokine (C-X-C motif) ligand 13 (CXCL13), macrophage migration inhibitory factor (MIF), and interleukin 35 (IL-35) levels in patients with primary Sjögren’s syndrome (pSS) and pSS-associated interstitial lung disease (pSS-ILD), and to exp...
Autores principales: | Wang, Ronghua, Yang, Yushu, Liu, Xuying, Lei, Lingyan, Qi, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485687/ https://www.ncbi.nlm.nih.gov/pubmed/37692029 http://dx.doi.org/10.5114/ceji.2023.127536 |
Ejemplares similares
-
MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015) -
Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren’s Syndrome
por: Chatzis, Loukas, et al.
Publicado: (2021) -
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children
por: Roider, Julia, et al.
Publicado: (2019) -
IL-27 Regulated CD4(+)IL-10(+) T Cells in Experimental Sjögren Syndrome
por: Qi, Jingjing, et al.
Publicado: (2020) -
MIF-Dependent Control of Tumor Immunity
por: Noe, Jordan T., et al.
Publicado: (2020)